The geoepidemiology of autoimmunity: Capsules from the 7th International Congress on autoimmunity, Ljubljana, Slovenia, may 2010

Israel Medical Association Journal

Volumn 13, Issue 2, 2011, Pages 121-127

  Carmi, Gal ^a,b   Amital, Howard ^a,b  

^a MEIR MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Autoimmunity; Geoepidemiology; Rheumatoid arthritis; Systemic lupus erythematosus; Systemic sclerosis

Indexed keywords

ALPHA INTERFERON; AUTOANTIGEN; HLA B27 ANTIGEN; NUCLEIC ACID; TOBACCO SMOKE;

ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPLEMENT SYSTEM; ENVIRONMENTAL FACTOR; EPIGENETICS; FEEDING BEHAVIOR; GENETIC PREDISPOSITION; GEOGRAPHIC DISTRIBUTION; GRAVES DISEASE; HEPATITIS C; HUMAN; LIFE STRESS; LUNG FIBROSIS; MULTIPLE SCLEROSIS; PATHOGENESIS; PREGNANCY; PSORIASIS; PSORIATIC ARTHRITIS; RHEUMATOID ARTHRITIS; SLOVENIA; SPONDYLOARTHROPATHY; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; THYROIDITIS; ULTRAVIOLET RADIATION;

ARTHRITIS, RHEUMATOID; AUTOIMMUNE DISEASES; CLUSTER ANALYSIS; CONGRESSES AS TOPIC; DISEASE PROGRESSION; EPIGENOMICS; GENETIC PREDISPOSITION TO DISEASE; GRAVES DISEASE; HUMANS; MULTIPLE SCLEROSIS; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SLOVENIA; SMOKING; SPONDYLARTHROPATHIES; STRESS, PSYCHOLOGICAL; SUNLIGHT; T-LYMPHOCYTES;

EID: 79952382435     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Brooks WH, Le DC, Pers JO, Youinou P, Renaudineau Y. Epigenetics and autoimmunity. J Autoimmun 2010; 34: J207-19.
2. Maverakis E, Miyamura Y, Bowen MP, Correa G, Ono Y, Goodarzi H. Light, including ultraviolet. J Autoimmun 2010; 34: J247-57.
3. Arnson Y, Shoenfeld Y, Amital H. Effects of tobacco smoke on immunity, inflammation and autoimmunity. J Autoimmun 2010; 34: J258-65.
4. Borchers AT, Naguwa SM, Keen CL, Gershwin ME. The implications of autoimmunity and pregnancy. J Autoimmun 2010; 34: J287-99.
5. Mackay IR. Travels and travails of autoimmunity: a historical journey from discovery to rediscovery. Autoimmun Rev 2010; 9: A251-8.
6. Selmi C, Tsuneyama K. Nutrition, geoepidemiology, and autoimmunity. Autoimmun Rev 2010; 9: A267-70.
7. Selmi C. The worldwide gradient of autoimmune conditions. Autoimmun Rev 2010; 9: A247-50.
8. Stojanovich L. Stress and autoimmunity. Autoimmun Rev 2010; 9: A271-6.
9. Chover-Gonzalez AJ, Harbuz MS, Tejedor-Real P, Gibert-Rahola J, Larsen PJ, Jessop DS. Effects of stress on susceptibility and severity of inflammation in adjuvant-induced arthritis. Ann N Y Acad Sci 1999; 876: 276-86.
10. Jessop DS, Douthwaite JA, Conde GL, Lightman SL, Dayan CM, Harbuz MS. Effects of acute stress or centrally injected interleukin-1beta on neuropeptide expression in the immune system. Stress 1997; 2: 133-44.
11. Mizokami T, Wu LA, El-Kaissi S, Wall JR. Stress and thyroid autoimmunity. Thyroid 2004; 14: 1047-55.
12. Mitsonis CI, Zervas IM, Mitropoulos PA, et al. The impact of stressful life events on risk of relapse in women with multiple sclerosis: a prospective study. Eur Psychiatry 2008; 23: 497-504.
13. Milo R, Kahana E. Multiple sclerosis: geoepidemiology, genetics and the environment. Autoimmun Rev 2010; 9: A387-94.
14. Kahana E, Zilber N, Abramson JH, Biton V, Leibowitz Y, Abramsky O. Multiple sclerosis: genetic versus environmental aetiology: epidemiology in Israel updated. J Neurol 1994; 241: 341-6.
15. Goldacre MJ, Seagroatt V, Yeates D, Acheson ED. Skin cancer in people with multiple sclerosis: a record linkage study. J Epidemiol Community Health 2004; 58: 142-4.
16. Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 2006; 296: 2832-8.
17. Borchers AT, Naguwa SM, Shoenfeld Y, Gershwin ME. The geoepidemiology of systemic lupus erythematosus. Autoimmun Rev 2010; 9: A277-87.
18. Uramoto KM, Michet CJ Jr, Thumboo J, Sunku J, O'Fallon WM, Gabriel SE. Trends in the incidence and mortality of systemic lupus erythematosus, 1950-1992. Arthritis Rheum 1999; 42: 46-50.
19. Serdula MK, Rhoads GG. Frequency of systemic lupus erythematosus in different ethnic groups in Hawaii. Arthritis Rheum 1979; 22: 328-33.
20. Danchenko N, Satia JA, Anthony MS. Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden. Lupus 2006; 15: 308-18.
21. Chakravarty EF, Bush TM, Manzi S, Clarke AE, Ward MM. Prevalence of adult systemic lupus erythematosus in California and Pennsylvania in 2000: estimates obtained using hospitalization data. Arthritis Rheum 2007; 56: 2092-4.
22. Tobon GJ, Youinou P, Saraux A. The environment, geo-epidemiology, and autoimmune disease: rheumatoid arthritis. Autoimmun Rev 2010; 9: A288-92.
23. Vieira VM, Hart JE, Webster TF, et al. Association between residences in U.S. northern latitudes and rheumatoid arthritis: A spatial analysis of the Nurses' Health Study. Environ Health Perspect 2010; 118: 957-61.
24. Vieira VM, Hart JE, Webster TF, et al. Association between residences in U.S. northern latitudes and rheumatoid arthritis: a spatial analysis of the Nurses' Health Study. Environ Health Perspect 2010; 118: 957-61.
25. Ehrenfeld M. Geoepidemiology: the environment and spondyloarthropathies. Autoimmun Rev 2010; 9: A325-9.
26. Ranque B, Mouthon L. Geoepidemiology of systemic sclerosis. Autoimmun Rev 2010; 9: A311-18.
27. Silman A, Jannini S, Symmons D, Bacon P. An epidemiological study of scleroderma in the West Midlands. Br J Rheumatol 1988; 27: 286-90.
28. Valesini G, Litta A, Bonavita MS, et al. Geographical clustering of scleroderma in a rural area in the province of Rome. Clin Exp Rheumatol 1993; 11: 41-7.
29. Arnett FC, Howard RF, Tan F, et al. Increased prevalence of systemic sclerosis in a Native American tribe in Oklahoma. Association with an Amerindian HLA haplotype. Arthritis Rheum 1996; 39: 1362-70.
30. Englert H, Joyner E, Bade R, et al. Systemic scleroderma: a spatiotemporal clustering. Intern Med J 2005; 35: 228-33.
31. Kamen DL, Cooper GS, Bouali H, Shaftman SR, Hollis BW, Gilkeson GS. Vitamin D deficiency in systemic lupus erythematosus. Autoimmun Rev 2006; 5: 114-17.
32. Whyte J, Artlett C, Harvey G, et al. HLA-DQB1 associations with antitopoisomerase-1 antibodies in patients with systemic sclerosis and their first degree relatives. United Kingdom Systemic Sclerosis Study Group. J Autoimmun 1994; 7: 509-20.
33. Hemminki K, Li X, Sundquist J, Sundquist K. The epidemiology of Graves' disease: evidence of a genetic and an environmental contribution. J Autoimmun 2010; 34: J307-13.
34. Y. Hepatitis C and interferon induced thyroiditis. J Autoimmun 2010; 34: J322-6.
35. Zeki AA, Schivo M, Chan AL, et al. Geoepidemiology of COPD and idiopathic pulmonary fibrosis. J Autoimmun 2010; 34: J327-38.
36. Hoffmann MH, Trembleau S, Muller S, Steiner G. Nucleic acid-associated autoantigens: pathogenic involvement and therapeutic potential. J Autoimmun 2010; 34: J178-206.
37. Chang C, Gershwin ME. Drugs and autoimmunity - a contemporary review and mechanistic approach. J Autoimmun 2010; 34: J266-75.
38. Chen M, Daha MR, Kallenberg CG. The complement system in systemic autoimmune disease. J Autoimmun 2010; 34: J276-86.